The perils of cheap fertility drugs
By Professor Bill Ledger,
BBC News
| 04. 21. 2010
[Commentary]
VIEWPOINT
Professor Bill Ledger, Professor of Obstetrics & Gynaecology, Sheffield University
During the 90s multiple births rose as doctors implanted a number of embryos into women having IVF - this has since been reduced.
But the multiple birth rate is still on the increase.
In this week's Scrubbing Up, leading fertility expert Professor Bill Ledger says part of the problem is the liberal use of cheap fertility drugs, and warns there will be dire consequences if this does not end.
There can be no doubt that having one child at a time is best for both mother and baby.
Multiple births often happen too early, with risk of neonatal illness needing intensive care, and sometimes permanent disability as a result.
Rates of twin and triplet birth were too high in the UK the 1990s because well-meaning fertility specialists were transferring too many embryos after IVF.
" These drugs need tighter control because whilst the high tech end of fertility medicine is highly regulated in UK, any doctor can prescribe these drugs "
The Human Fertilisation and Embryology Authority (HFEA) has...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Robyn Vinter, The Guardian | 11.09.2025
A man going by the name “Rod Kissme” claims to have “very strong sperm”. It may seem like an eccentric boast for a Facebook profile page, but then this is no mundane corner of the internet. The group where Rod...
